Skip to content
Events

Details

Questa sessione offre una panoramica su come le applicazioni per le malattie infettive e la microbiologia sulla serie MISeqᵀᴹ i100 possono supportare la sorveglianza genomica per la gestione delle epidemie, il controllo delle infezioni associate all'assistenza sanitaria (HAI), la lotta alla resistenza antimicrobica (AMR) o semplicemente per ottenere maggiori informazioni da i vostri campioni biologici utilizzando la metagenomica e la metatrascrittomica.

Rosy Volpi
Executive Territory Account Manager

Compila il modulo per accedere al webinar

Your email address is never shared with third parties.

Date & Time
12 Nov 2024
Location
Italy
Europe
Presenter
Rosy Volpi
Topic
Microbial genomics
Watch Now
 
 
M-EMEA-01741
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2026 Illumina, Inc. All rights reserved.